Document 0124 DOCN M9650124 TI Soluble tumor necrosis factor-alpha receptor type II (sTNF alpha RII) correlates with human immunodeficiency virus (HIV) RNA copy number in HIV-infected patients. DT 9605 AU Bilello JA; Stellrecht K; Drusano GL; Stein DS; Department of Medicine, Albany Medical College, New York 12208,; USA. SO J Infect Dis. 1996 Feb;173(2):464-7. Unique Identifier : AIDSLINE MED/96162110 AB Soluble TNF receptor type II (sTNF alpha RII) levels in serum, CD4 lymphocyte counts, and human immunodeficiency virus (HIV) burdens have each been correlated with HIV disease progression. The level of sTNF alpha RII and HIV RNA was measured in serum and the CD4 lymphocyte count of 25 HIV-infected patients was determined. sTNF alpha RII ranged between 3.019 and 12.57 ng/mL (mean +/- SD, 6.705 +/- 2.5). HIV-1 RNA varied from 960 to 281,160 copies/mL (71,988 +/- 75,684). CD4 cell number was between 4 and 540/microL (181.3 +/- 152.2). Univariate analysis revealed a moderate inverse correlation of sTNF alpha RII with CD4 cell number (r = -.41, P < .05) and a strong positive correlation between sTNF alpha RII and log RNA copy number (r = .62, P < .001). On multivariate analysis, sTNF alpha RII strongly correlated with RNA copy number (P < .01) but not CD4 lymphocyte count. sTNF alpha RII measurements appear to be predictive of clinical outcomes because they are a surrogate indicator of the patients' immunologic response to a virus load. DE Cross-Sectional Studies CD4 Lymphocyte Count CD4-Positive T-Lymphocytes/IMMUNOLOGY Enzyme-Linked Immunosorbent Assay Human HIV Infections/*BLOOD/PHYSIOPATHOLOGY/VIROLOGY HIV Seropositivity/BLOOD/PHYSIOPATHOLOGY/VIROLOGY HIV-1/*GENETICS Multivariate Analysis Polymerase Chain Reaction Receptors, Tumor Necrosis Factor/*ANALYSIS RNA, Viral/*ANALYSIS Solubility Support, Non-U.S. Gov't Viremia/IMMUNOLOGY/PHYSIOPATHOLOGY/*VIROLOGY JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).